META: Testosterone therapy for women addresses cognitive decline, libido, and mood in midlife. Evidence-led guide to female T-replacement, safety, and whether it’s right for you.
- Testosterone deficiency in women can cause brain fog, mood changes, and low libido — and it’s rarely tested or discussed in routine midlife care.
- Female testosterone therapy works for cognition and mood in some women, though clinical evidence is thinner than for HRT; dosing and monitoring are critical.
- Not everyone needs it, and oral testosterone carries hepatic risk — but transdermal patches and gels are safer options if your GP or specialist recommends it.
A woman walks into her GP’s surgery complaining she can’t concentrate, her mood’s in the gutter, and her libido has vanished. The doctor listens, prescribes an antidepressant, and sends her on her way. Nobody checks her testosterone. This happens dozens of times a week across the UK—and it’s arguably the biggest blind spot in women’s midlife health.
Last year, a Telegraph feature captured the quiet surge of women seeking testosterone replacement therapy for symptoms that don’t fit neatly into menopause checklists. One woman described the cognitive impact in brutal terms: she literally couldn’t count to ten without losing her place. Her testosterone was undetectable. After treatment started, her mind cleared. This isn’t anecdote dressed up as medicine—it’s the lived experience of an increasingly vocal group of women for whom hormone imbalance looks less like hot flushes and more like cognitive collapse.
The Testosterone Gap: Why Women’s Low T Goes Undiagnosed
Here’s the strange part: we know testosterone matters for women. It’s not a male hormone borrowed by accident. Women produce testosterone in the ovaries and adrenal glands, and circulating levels matter for bone density, muscle, cardiovascular health, mood, and cognition. Yet the UK’s clinical ecosystem treats female testosterone like a footnote.
GPs don’t routinely measure it.
Menopause clinics focus on oestrogen and progesterone. Training programmes rarely cover it. The result? Women with symptomatic testosterone deficiency—whether from early surgical menopause, autoimmune conditions, pituitary dysfunction, or age—often go years without answers.
The frustration is palpable, and justified. A woman aged 45 with brain fog and flatlined desire gets offered sertraline. Her testosterone sits at 0.5 nmol/L (well below the postmenopausal threshold of 0.7–2.8 nmol/L, though reference ranges vary), but nobody checks. Contrast this with a man with similar cognitive and mood symptoms: his GP orders a testosterone panel as standard. The double standard isn’t subtle.
Testosterone in women appears to influence dopamine and serotonin pathways, scaffold myelin, and support prefrontal cortex function. When it’s absent, cognition suffers—working memory, processing speed, executive function all take hits. Studies in ageing women suggest testosterone deficiency correlates with verbal memory decline and reduced cognitive resilience, though the field is still catching up with the clinical reality that many women experience.
What the Evidence Says About Female T-Therapy for Mood, Cognition, and Libido
Let’s be candid: the evidence base for female testosterone replacement is spottier than for HRT. But it’s not empty.
Libido and sexual function
This one’s well-studied. Multiple RCTs show testosterone patches improve sexual desire and arousal in postmenopausal women, particularly those with low baseline testosterone. The effect sizes are modest—typically a 1–2 point shift on a 10-point desire scale—but they’re real and reproducible. NICE doesn’t explicitly endorse testosterone for sexual dysfunction in women, but it’s increasingly prescribed off-label in specialist menopause clinics and by private practitioners.
Mood
Trickier. Testosterone influences limbic circuits and HPA axis tone. Some women report marked mood lift—less irritability, more resilience, improved motivation. Others notice nothing. The RCT evidence is mixed; most studies weren’t powered to detect mood change as a primary outcome. What we do know: women with concurrent hypogonadism (low testosterone) and depression sometimes improve when testosterone is added to antidepressants, but causation isn’t proven. If you’re considering T-therapy partly for mood, manage expectations. It might help. It might not.
Cognition
Here’s where clinical observation is outpacing research. Dozens of women report restored focus, faster processing, sharper memory after starting testosterone replacement. A 45-year-old who couldn’t complete sentences now writes articles. Another describes her brain “feeling switched back on” after months of fog. These aren’t placebo—they’re consistent, replicated anecdotally across forums and clinics. Yet formal RCTs in women are sparse. The evidence exists in pockets: small studies, observational data, and increasingly, clinician case series. Larger trials would be welcome, but they’re expensive and unglamorous.
Bottom line: if your only reason for wanting testosterone therapy is to improve cognition, know you’re entering territory where clinical experience outweighs high-grade trial evidence. That doesn’t mean it doesn’t work. It means the literature is playing catch-up with the clinic.
Wondering whether female testosterone therapy is right for you? Our specialists assess hormone profiles alongside symptom history to guide treatment decisions.
The Safety Question: Dosing, Monitoring, and Who Shouldn’t Take It
Testosterone in women isn’t risk-free. Neither is leaving it untreated if deficiency is causing real harm.
Oral testosterone carries hepatic risk—it’s metabolised heavily by the liver and can elevate liver enzymes and, rarely, cause cholestasis. Transdermal delivery (patches, gels, creams) bypasses first-pass metabolism and is safer, with more stable serum levels and fewer organ-level side effects. Most UK specialists now use patches (Tostran, Testogel) rather than oral forms, which is sensible.
Standard dosing ranges from 0.5–2 mg daily applied to skin, titrated upward based on blood testosterone levels (target range roughly 1.5–3 nmol/L for women, though no consensus exists). Monitoring matters: baseline testosterone, haematocrit, lipids, and liver function, then repeat bloodwork 6–8 weeks post-initiation and annually thereafter. Why? Testosterone can increase haematocrit (thicken blood slightly), shift lipid ratios, and—at higher doses—cause virilisation (voice deepening, clitoral enlargement, hair growth). These changes are usually dose-dependent and reverse if treatment stops, but they’re not trivial.
Who shouldn’t take it? Women with oestrogen-dependent cancers (breast, uterine) are generally advised against it, though some specialists argue data don’t clearly contraindicate use at physiological doses. The MHRA and British Menopause Society recommend caution; seek specialist input. Women with active cardiovascular disease, untreated sleep apnoea, severe polycythaemia, or poorly controlled lipids should get cardiology or endocrinology sign-off first.
Pregnancy is absolute contraindication. If you’re on testosterone and considering conception, stop it, allow three months for washout, and discuss with your GP or fertility specialist.
How to Access Female Testosterone Therapy in the UK
The NHS pathway is spotty. Some menopause clinics will prescribe testosterone for sexual dysfunction (coded as female sexual interest/arousal disorder), but availability varies wildly by region. Your best bet: ask your GP for referral to a menopause specialist or endocrinologist if you’ve got confirmed low testosterone and qualifying symptoms. If that stalls, private menopause clinics (increasingly common in London, Manchester, Edinburgh) often assess and prescribe more readily, though cost runs £200–600 for initial consultation plus pharmacy fees.
Before you go anywhere, know your baseline. Request full hormone panels—testosterone, SHBG (sex hormone-binding globulin; it affects free testosterone), oestradiol, FSH, prolactin, and thyroid function. Low libido without low testosterone is a different problem. Brain fog with normal hormones might point to thyroid disease, B12 deficiency, or undiagnosed sleep disorder. The diagnosis must fit.
Frequently Asked Questions
Can I get testosterone on the NHS for low mood or brain fog?
Unlikely, unless you’re in a menopause clinic that’s willing to prescribe off-label. The MHRA approves testosterone patches (Tostran) and gels only for HRT in oestrogen-deficient women, not specifically for mood or cognition. Your GP can prescribe it, but many won’t without specialist input, given liability concerns and inconsistent evidence.
Will testosterone make my voice deeper or give me facial hair?
Possible, but dose-dependent and rare at physiological replacement doses (0.5–2 mg daily). Voice changes are more common with higher doses or intramuscular injections (which aren’t standard for women in the UK). Transdermal gels minimise this risk. If virilisation occurs, it’s often reversible once you stop—though voice changes can persist.
How long before I notice a difference?
Libido: 4–8 weeks typically. Mood: 6–12 weeks, and less predictable. Cognition: variable; some women report sharpness within weeks, others see no change. If you’re not noticing anything by three months at an optimised dose, T-therapy probably isn’t your answer.
Can I use testosterone if I’m on HRT?
Yes. Some women use oestrogen and progesterone for vasomotor symptoms and cognitive decline whilst adding testosterone for libido and additional mood support. Dosing is individualised; your specialist will manage interactions.
What if my testosterone comes back “normal” but I have symptoms?
This happens. Reference ranges for women are loose, and some women feel optimally with higher testosterone levels. If your free testosterone (not just total) is in the lower quartile and you’ve got clear symptoms, some specialists will trial therapy anyway. Others won’t. Get a second opinion if you believe low T is driving your symptoms.
The fact that more women are asking about testosterone—and more clinicians are listening—suggests we’re finally catching up with a real gap in midlife health. Whether you’re struggling with brain fog, flatlined mood, or absent desire, the conversation has shifted from “that’s just what happens” to “let’s check.” That’s progress worth having, provided you go in with clear expectations and access proper monitoring. Your GP or menopause specialist can help you find the answer that fits.
